Dynamic, IPSC-derived hepatic tissue tri-culture system for the evaluation of liver physiology in vitro.

Hepatic Tissue IPSC Organ-on-a-chip Perfusion Stem Cell single cell RNAseq

Journal

Biofabrication
ISSN: 1758-5090
Titre abrégé: Biofabrication
Pays: England
ID NLM: 101521964

Informations de publication

Date de publication:
06 Mar 2024
Historique:
medline: 6 3 2024
pubmed: 6 3 2024
entrez: 6 3 2024
Statut: aheadofprint

Résumé

Availability of hepatic tissue for the investigation of metabolic processes is severely limited. While primary hepatocytes or animal models are widely used in pharmacological applications, a change in methodology towards more sustainable and ethical assays is highly desirable. Stem cell derived hepatic cells are generally regarded as a viable alternative for the above model systems, if current limitations in functionality and maturation can be overcome. By combining microfluidic organ-on-a-chip technology with individually differentiated, multicellular hepatic tissue fractions, we aim to improve overall functionality of hepatocyte-like cells, as well as evaluate cellular composition and interactions with non-parenchymal cell populations towards the formation of mature liver tissue. Utilizing a multi-omic approach, we show the improved maturation profiles of hepatocyte-like cells maintained in a dynamic microenvironment compared to standard tissue culture setups without continuous perfusion. In order to evaluate the resulting tissue, we employ single cell sequencing to distinguish formed subpopulations and spatial localization. While cellular input was strictly defined based on established differentiation protocols of parenchyma, endothelial and stellate cell fractions, resulting hepatic tissue was shown to comprise a complex mixture of epithelial and non-parenchymal fractions with specific local enrichment of phenotypes along the microchannel. Following this approach, we show the importance of passive, paracrine developmental processes in tissue formation. Using such complex tissue models is a crucial first step to develop stem cell-derived in vitro systems that can compare functionally with currently used pharmacological and toxicological applications.&#xD.

Identifiants

pubmed: 38447229
doi: 10.1088/1758-5090/ad30c5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 IOP Publishing Ltd.

Auteurs

Benedikt Scheidecker (B)

The University of Tokyo, CNRS UMI 2820, Institute of Industrial Science, Bunkyo-ku, Tokyo, 113-0033, JAPAN.

Stéphane Poulain (S)

The University of Tokyo, Institute of Industrial Science, Bunkyo-ku, Tokyo, 113-0033, JAPAN.

Masahiro Sugimoto (M)

Keio University, Institute for Advanced Biosciences, Keio University, Yamagata, 997-0035 , JAPAN.

Taketomo Kido (T)

The University of Tokyo, Institute for Quantitative Biosciences, Bunkyo-ku, Tokyo, 113-0033, JAPAN.

Takumi Kawanishi (T)

Kanazawa University, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa, 920-1192, JAPAN.

Atsushi Miyajima (A)

The University of Tokyo, Institute for Quantitative Biosciences, Bunkyo-ku, Tokyo, 113-0033, JAPAN.

Soo Hyeon Kim (SH)

The University of Tokyo, Institute of Industrial Science, Bunkyo-ku, Tokyo, 113-0033, JAPAN.

Hiroshi Arakawa (H)

Kanazawa University, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa, 920-1192, JAPAN.

Yukio Kato (Y)

Kanazawa University, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa, 920-1192, JAPAN.

Masaki Nishikawa (M)

The University of Tokyo, Department of Chemical System Engineering, Bunkyo-ku, Tokyo, 113-0033, JAPAN.

Mathieu Danoy (M)

The University of Tokyo, Department of Chemical System Engineering, Bunkyo-ku, Tokyo, 113-0033, JAPAN.

Yasuyuki Sakai (Y)

The University of Tokyo, Department of Chemical System Engineering, Bunkyo-ku, Tokyo, 113-0033, JAPAN.

Eric Leclerc (E)

The University of Tokyo, CNRS IRL 2820, Institute of Industrial Science, Bunkyo-ku, Tokyo, 113-0033, JAPAN.

Classifications MeSH